drugset / Trial / NCT00647972
Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan olanzapine 20 mg tablets to Eli Lilly Zyprexa® 20 mg tablets following a single, oral 20 mg (1 x 20 mg) dose administration under fasting conditions.
Timeline
- Start
- 2003-05
- Primary completion
- 2003-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 20 mg | Oral |
Indications
No indication recorded.